Only KRAS MT/p53 WT, but neither KRAS WT nor p53 MT NSCLC cells, showed a significant decrease in viability (Fig. 1A) and colony formation ability (Fig. 1B) after nutlin-3a treatment. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.